Celebrus Technologies plc (LON:CLBS - Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 145 ($1.99) and last traded at GBX 145 ($1.99), with a volume of 72701 shares traded. The stock had previously closed at GBX 150 ($2.06).
Celebrus Technologies Price Performance
The company has a market capitalization of £58.82 million, a price-to-earnings ratio of 14.58 and a beta of 1.34. The business has a fifty day moving average price of GBX 174.39 and a 200 day moving average price of GBX 214.84.
About Celebrus Technologies
(
Get Free Report)
As a disruptive data technology platform, Celebrus is focused on improving the relationships between brands and consumers via better data. Celebrus redefines what digital identity verification means to power both next-level marketing and fraud prevention use cases. Deployed across 30+ countries throughout the financial services, healthcare, retail, travel, and telecommunications sectors, Celebrus automatically captures, contextualises, and activates consumer behavioral data in live-time across all digital channels.
Read More
Before you consider Celebrus Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celebrus Technologies wasn't on the list.
While Celebrus Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
